Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Intevac (IVAC) Removes $6.50 PT on Maxim Group; Reiterates Hold Following 2Q
-
ADMA Biologics (ADMA) PT Raised to $12 at Maxim Group
-
UPDATE: Maxim Group Upgrades Cracker Barrel (CBRL) to Buy
-
Maxim Group Assumes Helios and Matheson Analytics (HMNY), Downgrades to Hold
-
Maxim Group Upgrades Eagle Bulk Shipping (EGLE) to Buy
-
Dolphin Entertainment Announces Closing Of $6.0 Million Public Offering Of Common Stock
-
Cytori Announces $6.7 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
TOP Ships Inc. Announces Termination of ATM Program and Other Corporate Developments
-
DineEquity (DIN) Added to Maxim Top Pick List
-
UPDATE: Darden (DRI)Removed From Maxim Top Pick List
-
Dave & Buster's Entertainment (PLAY) Added to Maxim Top Pick List
-
Dunkin' Brands (DNKN) Removed From Maxim Top Pick List
-
Dolphin Entertainment, Inc. (DLPN) Prices 2M Share Offering at $3/Sh
-
Dolphin Entertainment Announces Pricing Of $6.0 Million Public Offering Of Common Stock
-
SenesTech Reminds Investors of Today's Deadline to be a Shareholder of Record
-
Dolphin Entertainment, Inc. (DLPN) to Offer Common Stock
-
Dolphin Entertainment Announces Proposed Public Offering Of Common Stock
-
Priority Income Fund Successfully Invests Net Proceeds from Preferred Offering
-
Biocept Reminds Investors of Today's Deadline to be a Shareholder of Record
-
PlacementTracker Publishes First Half 2018 PIPE Market League Tables
-
Maxim Group Assumes IPass Inc. (IPAS) at Buy
-
Mesoblast Limited (MESO) PT Raised to $16 at Maxim Group
-
Domino's Pizza (DPZ) PT Raised to $285 at Maxim Group
-
China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing
-
SELLAS Life Sciences Announces Closing of $24.2 Million Public Offering
-
Cytori Reminds Stockholders That Rights Offering Expires on Friday, July 20
-
SenesTech, Inc. Announces Pricing Information for Rights Offering
-
Maxim Group Downgrades Darden Restaurants (DRI) to Hold Citing Valuation
-
Saratoga Investment Corp. Announces Completion of Public Offering of 1,150,000 Shares of Common Stock
-
SELLAS Life Sciences (SLS) Prices Upsized $24.2 Million Public Offering of Common Stock, Warrants
-
SELLAS Life Sciences Announces Pricing of Upsized $24.2 Million Public Offering
-
Maxim Group Starts Ebix, Inc. (EBIX) at Buy
-
Maxim Group Starts Virtra (VTSI) at Buy
-
Maxim Group Starts Yield10 Bioscience Inc (YTEN) at Buy
-
Saratoga Investment (SAR) Prices 1.15M Share Common Offering at $25/Sh
-
Biocept Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
-
Saratoga Investment Corp. Announces Pricing of Public Offering of Common Stock
-
Elevate Credit Inc (ELVT) PT Raised to $13 at Maxim Group
-
Maxim Group Upgrades ContraVir Pharma (CTRV) to Buy
-
SenesTech, Inc. Informs Stockholders of Key Dates Related to Announced Rights Offering
-
Matinas BioPharma Holdings Inc. (MTNB) PT Lowered to $3 at Maxim Group
-
Soligenix (SNGX) Capital Raise Strengthens the Balance Sheet - Maxim
-
Good Times Restaurants (GTIM) PT Raised to $7 at Maxim Group
-
Maxim Group Starts Identiv, Inc. (INVE) at Buy
-
Seanergy Maritime (SHIP) PT Lowered to $2 at Maxim Group
-
Oncolix, Inc. Expands Management Team with New Vice President of Corporate Development
-
Pre-Open Movers 07/03: (JNP) (AVXL) (AYI) Higher; (GLNCY) (DAL) (AAL) Lower (more...)
-
Maxim Group Starts Veru, Inc. (VERU) at Buy
-
Entera Bio Ltd. Announces Closing of Initial Public Offering
-
BioLife Solutions (BLFS) PT Raised to $18 at Maxim Group as Cell Media Revs Beat Expecations

